3,381 Shares in Agilent Technologies, Inc. $A Bought by Caxton Associates LLP

Key Points

• Caxton Associates LLP acquired 3,381 shares of Agilent Technologies, valued at approximately $396,000, marking a new investment during the 1st quarter.
• CEO Padraig Mcdonnell sold 1,508 shares, resulting in a 3.87% decrease in his holdings, which are now valued at around $4.4 million.
• Agilent Technologies reported earnings of $1.37 per share for the last quarter, meeting analysts' expectations, while also projecting 5.560-5.590 EPS for FY 2025.

Caxton Associates LLP purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 3,381 shares of the medical research company's stock, valued at approximately $396,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Sunbelt Securities Inc. increased its stake in Agilent Technologies by 640.0% during the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock worth $30,000 after buying an additional 192 shares during the period. Whipplewood Advisors LLC increased its stake in Agilent Technologies by 286.2% during the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock worth $29,000 after buying an additional 186 shares during the period. Wood Tarver Financial Group LLC purchased a new stake in Agilent Technologies during the 4th quarter worth $34,000. Stone House Investment Management LLC purchased a new stake in Agilent Technologies during the 1st quarter worth $30,000. Finally, Opal Wealth Advisors LLC purchased a new stake in Agilent Technologies during the 1st quarter worth $31,000.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the company's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares in the company, valued at approximately $4,397,893.12. This represents a 3.87% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $123.19 on Friday. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The firm has a 50-day simple moving average of $119.76 and a 200 day simple moving average of $115.99. The company has a market cap of $34.92 billion, a PE ratio of 28.92, a P/E/G ratio of 3.94 and a beta of 1.24.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting analysts' consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the prior year, the firm earned $1.32 EPS. The company's revenue for the quarter was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms recently issued reports on A. Leerink Partners lifted their price target on shares of Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research note on Friday, May 30th. Robert W. Baird boosted their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an "outperform" rating in a research report on Thursday, August 28th. TD Cowen boosted their target price on shares of Agilent Technologies to $150.00 and gave the stock a "buy" rating in a research report on Thursday, May 29th. UBS Group dropped their target price on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a research report on Thursday, May 29th. Finally, Wells Fargo & Company boosted their target price on shares of Agilent Technologies from $135.00 to $140.00 and gave the stock an "overweight" rating in a research report on Thursday, August 28th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $139.25.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.